22. Miller, A.D. and Rosman, G.: Improved retroviral vectors for gene transfer 
and expression. BioTechniques 7:980-990, 1989. 
23. Miller, A.D. and Buttiraore, C.: Redesign of retrovirus packaging cell 
lines to avoid recombination leading to helper virus production. Mol. Cell . 
Biol . 6:2895-2902, 1986. 
24. Kasid, A., Morecki, S., Aebersold, P. , Cornetta, K. , Culver, K. , Freeman, 
S., Director, E. , Lotze, M.T., Blaese, R.M. , Anderson, W.F. and Rosenberg, 
S.A.: human gene transfer: Characterization of human tumor-infiltrating 
lymphocytes as vehicles for retroviral-mediated gene transfer in man. 
Proc. Natl. Acad. Sci , USA, 87:473-477, 1990. 
|| 25. Rosenberg, S.A. , Aebersold, P. , Qpijnetta, K. , kasid. A., Morgan, R.A. , 
I Moen, R. , Karson, E.M., Lotze, M.T. , Yang, J.C., Topalian, S.L., Merino, 
M.J., Culver, K. , Miller, A.D. , Blaese, R.M. , Anderson, W.F.: Gene 
transfer into humans: Immunotherapy of patients with advanced melanoma 
I 
using tumor infiltrating lymphocytes modified by retroviral gene trans- 
duction. N Engl J Med (submitted). 
26. Topalian, S.L., Muul , L.M. , Solomon, D. , and Rosenberg, S.A.: Expansion 
of human tumor infiltrating lymphocytes for use in immunotherapy trials. 
J. Immunol. Meth . , 102:127-141, 1987. 
27. Cornetta, K. and Anderson, W.F. Protamine sulfate as an effective alternative 
to polybrene in retroviral-mediated gene transfer: Implications for human 
j gene therapy. J. Virol. Meth. 23:186-194, 1989. 
! 28. Rosenberg, S.A. , Grimm, E.A. , McGrogan, M. , Doyle, M. , Kawasaki, E. , Koths, 
j K. and Mark, D.F.: Biological activity of recombinant human interleukin-2 
produced in E. coli. Science 223:1412, 1984. 
29. Cornetta, K. , Morgan, R.A. and Anderson, W.F.: Safety issues related to 
retroviral-mediated gene transfer in humans. Nature (submitted) 
Recombinant DNA Research, Volume 14 
[287] 
